Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1/2 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Breast Neoplasms 15Neoplasms 8cyclopia sequence 7Prostatic Neoplasms 7Polycystic Ovary Syndrome 5Fatigue 5Lung Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain 3Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Leiomyoma 3Vomiting 2Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Nausea 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Insulin Resistance 2Infertility 2Hyperandrogenism 2Hematologic Diseases 2Depression 2Burkitt Lymphoma 2Weight Loss 1

Interventions

Cisplatin 252Radiotherapy 176Cetuximab 144pembrolizumab 120Docetaxel 96Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Gefitinib 21Cyclophosphamide 21Surveys and Questionnaires 20Surgical Procedures, Operative 19Standard of Care 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15Low-Level Light Therapy 14Everolimus 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × Sugars × Clear all
NCT01330446 2024-02-14

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Head & Neck

Fatigue, Head and Neck Neoplasms

NCT00536172 2023-09-21

PROTECT

University of Nebraska

Phase 4 Completed
160 enrolled 15 charts
Head & Neck

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT02055963 2022-10-20

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
30 enrolled 9 charts
Head & Neck

cyclopia sequence, Head and Neck Neoplasms

NCT01427205 2013-04-05

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡